DPRXP7

Across TCGA pan-cancer cohorts, DPRXP7 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated DPRXP7 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher DPRXP7 RNA is associated with better overall survival. In most high-consensus cancer types, elevated DPRXP7 expression acts as an unfavorable survival marker, although some lineages such as THCA and LUSC show a favorable association.

THCA, HNSC, and LUSC are the cancer types where DPRXP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Median	II,III,IV	1.000	0.557	.005	42	view →
HNSC	DFS	Tertile	All	0.212	0.606	.003	36	view →
LUSC	OS	Tertile	All	0.924	0.764	.026	15	view →
TGCT	DFS	Tertile	All	0.915	0.737	.011	12	view →
PCPG	OS	Tertile	All	0.714	0.963	<.001	9	view →
LIHC	OS	Tertile	II,III,IV	0.255	0.768	.018	9	view →
PAAD	OS	Tertile	All	0.526	0.355	.037	6	view →
SKCM	OS	Tertile	II,III,IV	0.375	0.734	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

DPRXP7–THCA (OS)

Open the THCA breakdown →